Welcome to the March 2013 issue of Sourcing and Management, Pharmaceutical Technology’s and Pharmaceutical Technology Europe’s information resource on pharmaceutical ingredients, manufacturing, and the supply chain. In this issue, an outlook of the global API market and a roundup of expansion news of contract API manufacturers and fine chemical producers. Also, a look at the benefits of incremental pharmaceutical innovation on global health outcomes and other news from the pharmaceutical/biopharmaceutical companies and their suppliers relating to global health initiatives and sustainability.

APIs
The Weaknesses and Strengths of the Global API Market
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Supply-demand fundamentals show strong growth for generic APIs as gains in innovator APIs lag.

Contract Manufacturing
Fine-Chemical Producers Outline Expansion Plans at Informex
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Contract API manufacturers and fine-chemical producers proceed with select investment in capacity and service additions.

Outsourcing
End of the Dedicated CMO?
Jim Miller, president of PharmSource Information Services
Is the contract-only CMO an endangered species?

Pharma Industry’s Global Health and Sustainability Forum
Pharma News in Global Health and Sustainability
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

Pharma Industry Outlines Opportunity for Incremental Innovation to Improve Global Health
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Incremental innovation advances medicines by expanding therapeutic classes, increasing the number of available dosing options, discovering new physiological interactions of known medicines, and improving other properties of existing medicines.